Literature DB >> 1748871

Synergistic action of nikkomycin X/Z with azole antifungals on Candida albicans.

S Milewski1, F Mignini, E Borowski.   

Abstract

Fluconazole, ketoconazole and tioconazole were shown to act synergistically in vitro with the antibiotic nikkomycin X/Z on the pathogenic fungus Candida albicans. The phenomenon was demonstrated using a checkerboard technique and growth inhibition experiments. The azole antifungal agents, even at concentrations not affecting growth, decreased the incorporation of the 14C-label from [14C]glucose into chitin of the candidal cell wall. After 3 h incubation with tioconazole, 1 microgram ml-1, the incorporation of the radiolabelled glucose into chitin of intact cells and regenerating spheroplasts of C. albicans was inhibited by 43% and 30%, respectively. Moreover, the relative chitin content was approximately 45% lower than that of control cells. The chitin content increased after prolonged incubation with azoles, thus confirming the known phenomenon of azole-induced uncoordinated chitin synthesis and deposition. On the other hand, azole derivatives had very little effect on the rate of nikkomycin transport into C. albicans cells. A sequential blockade mechanism of synergism is proposed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748871     DOI: 10.1099/00221287-137-9-2155

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  10 in total

Review 1.  Compounds active against cell walls of medically important fungi.

Authors:  R F Hector
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

2.  Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro.

Authors:  V N Tariq; E M Scott; N E McCain
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

3.  In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole.

Authors:  R K Li; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

Review 4.  Sweet Rules: Linking Glycosylation to Antibody Function.

Authors:  Falk Nimmerjahn; Anja Werner
Journal:  Exp Suppl       Date:  2021

5.  Nikkomycin Z supersensitivity of an echinocandin-resistant mutant of Saccharomyces cerevisiae.

Authors:  M el-Sherbeini; J A Clemas
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo.

Authors:  R F Hector; K Schaller
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

7.  Initial Results of the International Efforts in Screening New Agents against Candida auris.

Authors:  Vanice Rodrigues Poester; Lívia Silveira Munhoz; Jéssica Louise Benelli; Aryse Martins Melo; Abdullah M S Al-Hatmi; David J Larwood; Marife Martinez; David A Stevens; Melissa Orzechowski Xavier
Journal:  J Fungi (Basel)       Date:  2022-07-25

8.  Calcofluor white combination antifungal treatments for Trichophyton rubrum and Candida albicans.

Authors:  Joanne M Kingsbury; Joseph Heitman; Sheldon R Pinnell
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

9.  Chemosensitization of multidrug resistant Candida albicans by the oxathiolone fused chalcone derivatives.

Authors:  Izabela Ła̧cka; Marek T Konieczny; Anita Bułakowska; Marie Kodedová; Dana Gašková; Indresh K Maurya; Rajendra Prasad; Sławomir Milewski
Journal:  Front Microbiol       Date:  2015-08-05       Impact factor: 5.640

10.  Fluconazole and Lipopeptide Surfactin Interplay During Candida albicans Plasma Membrane and Cell Wall Remodeling Increases Fungal Immune System Exposure.

Authors:  Jakub Suchodolski; Daria Derkacz; Jakub Muraszko; Jarosław J Panek; Aneta Jezierska; Marcin Łukaszewicz; Anna Krasowska
Journal:  Pharmaceutics       Date:  2020-04-01       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.